Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in February-March
India | January 08, 2021 12:17 ISTBesides Covaxin, Bharat Biotech has been actively working on developing another vaccine, for which it tied up with Washington University School of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee adenovirus), a single dose in tranasal vaccine for COVID-19.